Furthermore, ILC3s have been shown to exert antitumor effects on HCC and melanoma cells via IFN-γ release and Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent cytotoxicity stemming from direct recognition 95. Here, IFNG is linked to hepatocellular carcinoma.